- Home
- Publications
- Publication Search
- Publication Details
Title
Effect of Prostanoids on Human Platelet Function: An Overview
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 21, Issue 23, Pages 9020
Publisher
MDPI AG
Online
2020-11-27
DOI
10.3390/ijms21239020
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Integration of Rap1 and Calcium Signaling
- (2020) Ramoji Kosuru et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- A Review of Prostanoid Receptors: Expression, Characterization, Regulation, and Mechanism of Action
- (2020) Roger G. Biringer Journal of Cell Communication and Signaling
- A novel approach of platelet function test for prediction of attenuated response to clopidogrel
- (2019) Erzsebet Ezer et al. CLINICAL HEMORHEOLOGY AND MICROCIRCULATION
- Prostaglandin F2α Facilitates Platelet Activation by Acting on Prostaglandin E2 Receptor Subtype EP3 and Thromboxane A2 Receptor TP in Mice
- (2019) Hitoshi Kashiwagi et al. THROMBOSIS AND HAEMOSTASIS
- The pleiotropic effects of antiplatelet therapies
- (2019) Helen Ullrich et al. CLINICAL HEMORHEOLOGY AND MICROCIRCULATION
- Measurement of Thromboxane Biosynthesis in Health and Disease
- (2019) Carlo Patrono et al. Frontiers in Pharmacology
- A Phase 2a Study of DP2 antagonist GB001 for Asthma
- (2019) Koichiro Asano et al. Journal of Allergy and Clinical Immunology-In Practice
- Oxygenation of polyunsaturated fatty acids and oxidative stress within blood platelets
- (2018) Michel Lagarde et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Eicosanoids, prostacyclin and cyclooxygenase in the cardiovascular system
- (2018) Jane A Mitchell et al. BRITISH JOURNAL OF PHARMACOLOGY
- Eicosanoids in platelets and the effect of their modulation by aspirin in the cardiovascular system (and beyond)
- (2018) Marilena Crescente et al. BRITISH JOURNAL OF PHARMACOLOGY
- Bioresorbable everolimus-eluting vascular scaffold for patients presenting with non STelevation-acute coronary syndrome: A three-years follow-up1
- (2018) Remzi Anadol et al. CLINICAL HEMORHEOLOGY AND MICROCIRCULATION
- Hypercoagulable state in sickle cell disease
- (2018) Camille Faes et al. CLINICAL HEMORHEOLOGY AND MICROCIRCULATION
- Comparison of two substrate materials used as negative control in endothelialization studies: Glass versus polymeric tissue culture plate
- (2018) Anne Krüger-Genge et al. CLINICAL HEMORHEOLOGY AND MICROCIRCULATION
- Selectively targeting prostanoid E (EP) receptor-mediated cell signalling pathways: Implications for lung health and disease
- (2018) Leonard F. Lebender et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- Intracellular platelet signalling as a target for drug development
- (2018) Gemma Vilahur et al. VASCULAR PHARMACOLOGY
- Prostaglandin D2 receptor antagonists in allergic disorders: safety, efficacy, and future perspectives
- (2018) Giancarlo Marone et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Regulation and physiological functions of mammalian phospholipase C
- (2017) Yoshikazu Nakamura et al. JOURNAL OF BIOCHEMISTRY
- The expansive role of oxylipins on platelet biology
- (2017) Jennifer Yeung et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Prostanoids in the pathophysiology of human coronary artery
- (2017) G. Ozen et al. PROSTAGLANDINS & OTHER LIPID MEDIATORS
- Human Endothelial Cell Models in Biomaterial Research
- (2017) Sandra Hauser et al. TRENDS IN BIOTECHNOLOGY
- Targeting the Prostacyclin Pathway: Beyond Pulmonary Arterial Hypertension
- (2017) Hélène Pluchart et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Membrane Ballooning in Aggregated Platelets is Synchronised and Mediates a Surge in Microvesiculation
- (2017) Ejaife O. Agbani et al. Scientific Reports
- Platelets and coronary artery disease: Interactions with the blood vessel wall and cardiovascular devices
- (2016) Markus Reinthaler et al. Biointerphases
- New Developments in Platelet Cyclic Nucleotide Signalling: Therapeutic Implications
- (2016) Nathan E. K. Procter et al. CARDIOVASCULAR DRUGS AND THERAPY
- Phosphorylation of Rap1 by cAMP-dependent Protein Kinase (PKA) Creates a Binding Site for KSR to Sustain ERK Activation by cAMP
- (2016) Maho Takahashi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Pharmacotherapy for Erectile Dysfunction: Recommendations From the Fourth International Consultation for Sexual Medicine (ICSM 2015)
- (2016) Konstantinos Hatzimouratidis et al. Journal of Sexual Medicine
- The effect of alprostadil on preventing contrast-induced nephropathy for percutaneous coronary intervention in diabetic patients
- (2016) Ziliang Ye et al. MEDICINE
- Treprostinil Iontophoresis Improves Digital Blood Flow during Local Cooling in Systemic Sclerosis
- (2016) Florence Gaillard-Bigot et al. MICROCIRCULATION
- Platelets and coronary artery disease: Interactions with the blood vessel wall and cardiovascular devices
- (2016) Markus Reinthaler et al. Biointerphases
- Acute Thrombogenicity of a Durable Polymer Everolimus-Eluting Stent Relative to Contemporary Drug-Eluting Stents With Biodegradable Polymer Coatings Assessed Ex Vivo in a Swine Shunt Model
- (2015) Fumiyuki Otsuka et al. JACC-Cardiovascular Interventions
- RAP1-GTPase signaling and platelet function
- (2015) Lucia Stefanini et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Prostanoids regulate angiogenesis acting primarily on IP and EP 4 receptors
- (2015) Khuyen Gia Hoang et al. MICROVASCULAR RESEARCH
- Prostacyclin protects vascular integrity via PPAR/14-3-3 pathway
- (2015) Ling-yun Chu et al. PROSTAGLANDINS & OTHER LIPID MEDIATORS
- Understanding the role of prostaglandin E2 in regulating human platelet activity in health and disease
- (2015) Eitan A. Friedman et al. THROMBOSIS RESEARCH
- Prostacyclin Signaling Boosts NADPH Oxidase 4 in the Endothelium Promoting Cytoprotection and Angiogenesis
- (2014) Hitesh M. Peshavariya et al. ANTIOXIDANTS & REDOX SIGNALING
- Prostaglandin E3 metabolism and cancer
- (2014) Peiying Yang et al. CANCER LETTERS
- Reciprocal regulation of human platelet function by endogenous prostanoids and through multiple prostanoid receptors
- (2014) Katharina Hubertus et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Update on the status of DP2 receptor antagonists; from proof of concept through clinical failures to promising new drugs
- (2013) Peter Norman EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Prostaglandin F2α FP receptor antagonist improves outcomes after experimental traumatic brain injury
- (2013) Alexander V Glushakov et al. Journal of Neuroinflammation
- The role of prostaglandin E2 in human vascular inflammation
- (2013) I. Gomez et al. PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS
- Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010
- (2012) Rafael Lozano et al. LANCET
- Prostaglandin FP receptor inhibitor reduces ischemic brain damage and neurotoxicity
- (2012) Yun Tai Kim et al. NEUROBIOLOGY OF DISEASE
- The role of prostanoid receptors in mediating the effects of PGE3 on human platelet function
- (2012) David Iyú et al. THROMBOSIS AND HAEMOSTASIS
- Pulmonary Hypertension
- (2011) Ali Salehi AMERICAN JOURNAL OF THERAPEUTICS
- Novel roles of cAMP/cGMP-dependent signaling in platelets
- (2011) A. SMOLENSKI JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- The role of PGE2 in human atherosclerotic plaque on platelet EP3 and EP4 receptor activation and platelet function in whole blood
- (2011) Lisa J. Schober et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): a randomised, double-blind, parallel-group trial
- (2011) Marie-Germaine Bousser et al. LANCET
- Degradable, Multifunctional Cardiovascular Implants: Challenges and Hurdles
- (2011) Friedrich Jung et al. MRS BULLETIN
- Arterial thrombus formation in cardiovascular disease
- (2011) Giuseppe Lippi et al. Nature Reviews Cardiology
- Omega-3 fatty acids attenuate constitutive and insulin-induced CD36 expression through a suppression of PPARα/γ activity in microvascular endothelial cells
- (2011) Rosalinda Madonna et al. THROMBOSIS AND HAEMOSTASIS
- The Prostaglandin E 2 Receptor EP4 Is Expressed by Human Platelets and Potently Inhibits Platelet Aggregation and Thrombus Formation
- (2010) Sonia Philipose et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Prostaglandin E2 Differentially Modulates Human Platelet Function through the Prostanoid EP2 and EP3 Receptors
- (2010) G. Petrucci et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- The role of prostanoid receptors in mediating the effects of PGE2on human platelet function
- (2010) David Iyú et al. PLATELETS
- PGE1 and PGE2 modify platelet function through different prostanoid receptors
- (2010) David Iyú et al. PROSTAGLANDINS & OTHER LIPID MEDIATORS
- Selective activation of the prostaglandin E2 receptor subtype EP2 or EP4 leads to inhibition of platelet aggregation
- (2010) Koh-ichi Yuhki et al. THROMBOSIS AND HAEMOSTASIS
- PGE2 decreases reactivity of human platelets by activating EP2 and EP4
- (2010) James P. Smith et al. THROMBOSIS RESEARCH
- PG F2α Receptor: A Promising Therapeutic Target for Cardiovascular Disease
- (2010) Jian Zhang et al. Frontiers in Pharmacology
- ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension
- (2009) et al. CIRCULATION
- Induction of Prostacyclin by Steady Laminar Shear Stress Suppresses Tumor Necrosis Factor-α Biosynthesis via Heme Oxygenase-1 in Human Endothelial Cells
- (2009) Luigia Di Francesco et al. CIRCULATION RESEARCH
- Prostaglandin F2 elevates blood pressure and promotes atherosclerosis
- (2009) Y. Yu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Modulation of angiogenesis by -3 polyunsaturated fatty acids is mediated by cyclooxygenases
- (2008) M. Szymczak et al. BLOOD
- DG-041 inhibits the EP3 prostanoid receptor—A new target for inhibition of platelet function in atherothrombotic disease
- (2008) Stan Heptinstall et al. PLATELETS
- Physiological Regulation of Prostaglandins in the Kidney
- (2007) Chuan-Ming Hao et al. Annual Review of Physiology
- The opposing effects of n−3 and n−6 fatty acids
- (2007) Gerd Schmitz et al. PROGRESS IN LIPID RESEARCH
- PGF2α-associated vascular smooth muscle hypertrophy is ROS dependent and involves the activation of mTOR, p70S6k, and PTEN
- (2007) K.M. Rice et al. PROSTAGLANDINS & OTHER LIPID MEDIATORS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More